AMSilk Closes 5 Million Euro Financing Round
AMSilk announced the successful completion of a 5 million Euro Series B financing round. Investors include MIG Fonds 6, MIG Fonds 7 and MIG Fonds 11, as well as AT Newtec. The newly raised funds will secure AMSilk’s advancement and commercialization efforts for its first spider silk-based products.
AMSilk produces and processes SPIDERSILK, high performance biopolymers copied from the proteins of web-weaving spiders. SPIDERSILK has unique properties such as mechanical toughness, chemical resistance and biocompatibility - while being completely biodegradable. AMSilk is able to produce SPIDERSILK in large scale and produce coatings, beads, films, nonwovens, and fibers used to improve existing or to develop completely new products. AMSilk is, together with various partners, developing several applications for this new material. The successful kilogram-scale production and the continuous development of optimized processing parameters since the company foundation in 2008 were important prerequisites for the new series B financing round.
"We are excited to continue our partnership with the investors who have supported us since the company formation in 2008,” says Axel Leimer, Managing Director of AMSilk. “There is an urgent need to develop new and superior cleantech products with a smaller environmental footprint and previously unachievable features. The newly raised funds will be used to commercialize our products through partnerships with leading companies across major industries," added Leimer.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
